Search

Mychal James Bradley Gibbens

Examiner (ID: 6474)

Most Active Art Unit
2662
Art Unit(s)
2662
Total Applications
2
Issued Applications
2
Pending Applications
0
Abandoned Applications
0

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 11823185 [patent_doc_number] => 20170212120 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-07-27 [patent_title] => 'SELECTED REACTION MONITORING ASSAYS' [patent_app_type] => utility [patent_app_number] => 15/476118 [patent_app_country] => US [patent_app_date] => 2017-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 17536 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15476118 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/476118
Selected reaction monitoring assays Mar 30, 2017 Issued
Array ( [id] => 11742866 [patent_doc_number] => 20170196938 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-07-13 [patent_title] => 'CARRIER-FREE BIOLOGICALLY-ACTIVE PROTEIN NANOSTRUCTURES' [patent_app_type] => utility [patent_app_number] => 15/470169 [patent_app_country] => US [patent_app_date] => 2017-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 14465 [patent_no_of_claims] => 108 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15470169 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/470169
Carrier-free biologically-active protein nanostructures Mar 26, 2017 Issued
Array ( [id] => 11971196 [patent_doc_number] => 20170275350 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-09-28 [patent_title] => 'Protease Activated Receptor-1 (PAR1) Derived Cytoprotective Polypeptides and Related Methods' [patent_app_type] => utility [patent_app_number] => 15/470117 [patent_app_country] => US [patent_app_date] => 2017-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 21123 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15470117 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/470117
Protease activated receptor-1 (PAR1) derived cytoprotective polypeptides and related methods Mar 26, 2017 Issued
Array ( [id] => 13968305 [patent_doc_number] => 10213486 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-02-26 [patent_title] => Formulations of diluted amino acid segments and methods for making same [patent_app_type] => utility [patent_app_number] => 15/470239 [patent_app_country] => US [patent_app_date] => 2017-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13877 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15470239 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/470239
Formulations of diluted amino acid segments and methods for making same Mar 26, 2017 Issued
Array ( [id] => 11727955 [patent_doc_number] => 20170189398 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-07-06 [patent_title] => 'METHODS AND COMPOSITIONS FOR SLEEP DISORDERS AND OTHER DISORDERS' [patent_app_type] => utility [patent_app_number] => 15/467867 [patent_app_country] => US [patent_app_date] => 2017-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12396 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15467867 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/467867
Methods and compositions for sleep disorders and other disorders Mar 22, 2017 Issued
Array ( [id] => 14145463 [patent_doc_number] => 10253090 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-04-09 [patent_title] => Hydrolyzed collagen compositions and methods of making thereof [patent_app_type] => utility [patent_app_number] => 15/569240 [patent_app_country] => US [patent_app_date] => 2017-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4979 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 112 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15569240 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/569240
Hydrolyzed collagen compositions and methods of making thereof Mar 19, 2017 Issued
Array ( [id] => 16596726 [patent_doc_number] => 20210023257 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-01-28 [patent_title] => CEREBROSPINAL FLUID LEAKAGE OCCLUSION [patent_app_type] => utility [patent_app_number] => 16/085803 [patent_app_country] => US [patent_app_date] => 2017-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9771 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16085803 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/085803
CEREBROSPINAL FLUID LEAKAGE OCCLUSION Mar 16, 2017 Abandoned
Array ( [id] => 11977619 [patent_doc_number] => 20170281774 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-10-05 [patent_title] => 'LINACLOTIDE COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 15/461923 [patent_app_country] => US [patent_app_date] => 2017-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 14671 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15461923 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/461923
LINACLOTIDE COMPOSITIONS Mar 16, 2017 Abandoned
Array ( [id] => 16288803 [patent_doc_number] => 10765625 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-09-08 [patent_title] => Knottin-drug conjugates and methods of using the same [patent_app_type] => utility [patent_app_number] => 15/458852 [patent_app_country] => US [patent_app_date] => 2017-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 18 [patent_no_of_words] => 12562 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15458852 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/458852
Knottin-drug conjugates and methods of using the same Mar 13, 2017 Issued
Array ( [id] => 18153084 [patent_doc_number] => 11566045 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-01-31 [patent_title] => Tumor targeting polypeptide and method of use thereof [patent_app_type] => utility [patent_app_number] => 15/562722 [patent_app_country] => US [patent_app_date] => 2017-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 9976 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15562722 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/562722
Tumor targeting polypeptide and method of use thereof Mar 13, 2017 Issued
Array ( [id] => 12023645 [patent_doc_number] => 20170313745 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-11-02 [patent_title] => 'INHIBITORS OF HEPATITIS C VIRUS' [patent_app_type] => utility [patent_app_number] => 15/455508 [patent_app_country] => US [patent_app_date] => 2017-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 52232 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15455508 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/455508
INHIBITORS OF HEPATITIS C VIRUS Mar 9, 2017 Abandoned
Array ( [id] => 16042935 [patent_doc_number] => 10683326 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-06-16 [patent_title] => Crystalline salt forms [patent_app_type] => utility [patent_app_number] => 16/084168 [patent_app_country] => US [patent_app_date] => 2017-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 36 [patent_no_of_words] => 25022 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16084168 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/084168
Crystalline salt forms Mar 9, 2017 Issued
Array ( [id] => 14043477 [patent_doc_number] => 20190077845 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-03-14 [patent_title] => METHODS OF PURIFYING COLLAGEN 7 [patent_app_type] => utility [patent_app_number] => 16/084998 [patent_app_country] => US [patent_app_date] => 2017-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11653 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 150 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16084998 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/084998
Methods of purifying collagen 7 Mar 9, 2017 Issued
Array ( [id] => 14143157 [patent_doc_number] => 10251930 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-04-09 [patent_title] => Treatment of degenerative joint disease [patent_app_type] => utility [patent_app_number] => 15/453573 [patent_app_country] => US [patent_app_date] => 2017-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 8995 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15453573 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/453573
Treatment of degenerative joint disease Mar 7, 2017 Issued
Array ( [id] => 13805287 [patent_doc_number] => 10179905 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-01-15 [patent_title] => Factor VII conjugates [patent_app_type] => utility [patent_app_number] => 15/453188 [patent_app_country] => US [patent_app_date] => 2017-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 9 [patent_no_of_words] => 15290 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15453188 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/453188
Factor VII conjugates Mar 7, 2017 Issued
Array ( [id] => 13263353 [patent_doc_number] => 10143746 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-12-04 [patent_title] => Immunomodulators [patent_app_type] => utility [patent_app_number] => 15/446298 [patent_app_country] => US [patent_app_date] => 2017-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 45416 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15446298 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/446298
Immunomodulators Feb 28, 2017 Issued
Array ( [id] => 11969892 [patent_doc_number] => 20170274047 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-09-28 [patent_title] => 'ANALOGS OF SHK TOXIN AND THEIR USES IN SELECTIVE INHIBITION OF KV1. 3 POTASSIUM CHANNELS' [patent_app_type] => utility [patent_app_number] => 15/445423 [patent_app_country] => US [patent_app_date] => 2017-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 12634 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15445423 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/445423
ANALOGS OF SHK TOXIN AND THEIR USES IN SELECTIVE INHIBITION OF KV1. 3 POTASSIUM CHANNELS Feb 27, 2017 Abandoned
Array ( [id] => 11707954 [patent_doc_number] => 20170176452 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-06-22 [patent_title] => 'THYROGLOBULIN QUANTITATION BY MASS SPECTROSCOPY' [patent_app_type] => utility [patent_app_number] => 15/443805 [patent_app_country] => US [patent_app_date] => 2017-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 10598 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15443805 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/443805
Thyroglobulin quantitation by mass spectroscopy Feb 26, 2017 Issued
Array ( [id] => 11707952 [patent_doc_number] => 20170176451 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-06-22 [patent_title] => 'KISSPEPTIN-54 DETECTION BY TANDEM MASS SPECTROMETRY' [patent_app_type] => utility [patent_app_number] => 15/443645 [patent_app_country] => US [patent_app_date] => 2017-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 12471 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15443645 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/443645
Kisspeptin-54 detection by tandem mass spectrometry Feb 26, 2017 Issued
Array ( [id] => 14338891 [patent_doc_number] => 20190151418 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-05-23 [patent_title] => COMBINATION OF CALCIUM-PHOSPHATE-CONTAINING POROUS COMPOSITE AND PTH [patent_app_type] => utility [patent_app_number] => 16/091632 [patent_app_country] => US [patent_app_date] => 2017-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11223 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16091632 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/091632
COMBINATION OF CALCIUM-PHOSPHATE-CONTAINING POROUS COMPOSITE AND PTH Feb 23, 2017 Abandoned
Menu